Opicapone as adjunctive to levodopa-treated Parkinson’s disease patients without motor without motor complications: preliminary data from the EPSILON Study

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

Daraio, E., Rascol, O., Stocchi, F., Antonini, A., Moreira, J., Castilla-Fernández, G., Rocha, J., Holenz, J., Poewe, W.

Aug 31, 2023